Clinical Trials in Arizona

Showing 10421-10440 of 14,395 trials

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00935792

RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the signaling molecules needed for cell growth. Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. PURPOSE: This phase I/II trial is studying the side effects and best dose of everolimus when given together with alemtuzumab and will see how well they work in treating patients with recurrent chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).

Lymphocytic Leukemia

Mayo Clinic28 participantsStarted Jul 2009

Scottsdale, Arizona, United States • Rochester, Minnesota, United States

TERMINATEDPhase 231 miles

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

NCT01340794

This phase II trial studies how well pazopanib hydrochloride works in treating patients with advanced or progressive malignant pheochromocytoma or paraganglioma. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Extra-Adrenal ParagangliomaMetastatic Adrenal Gland PheochromocytomaParaganglioma+1 more

National Cancer Institute (NCI)7 participantsStarted May 2011

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Baltimore, Maryland, United States +8 more locations

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

Find Trials by Condition in Arizona

Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease

Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

Physiologic Definition of Bronchopulmonary Dysplasia

Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Oral Rivaroxaban in Children With Venous Thrombosis

Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease

N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children

Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer